Cushman, Mark S

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Selective Janus Kinase Inhibitors for Autoimmune Disease
2018-CUSH-68109
  1. Medical/Health
Cushman, Mark S
Simultaneous Treatment of Alcohol Use and Psychiatric Disorders
2017-VANR-67884
  1. Pharmaceuticals
  2. Medical/Health
Van Rijn, Richard M.
Second Generation Phenylthiazole Antibiotics for Treatment of MRSA
2016-CUSH-67515
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Cushman, Mark S
Top1/TDP1/TDP2 Triple Inhibitor Anticancer Agents
2017-CUSH-67685
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Cushman, Mark S
Aromatase Inhibitor Breast Cancer Therapeutics with Reduced Potential for Side Effects
2016-CUSH-67271
  1. Pharmaceuticals
  2. Medical/Health
Cushman, Mark S
Antitumor Norindenoisoquinoline Topoisomerase 1 Inhibitors
65410
  1. Chemical Engineering
  2. Pharmaceuticals
Cushman, Mark S
Topoisomerase I Inhibitors as Potential Anticancer Agents
65643
  1. Chemical Engineering
  2. Pharmaceuticals
Cushman, Mark S
Topoisomerase I Inhibitors Substituted with Carbohydrates
65707
  1. Biotechnology
  2. Pharmaceuticals
Cushman, Mark S
7-Azaindenoisoquinolines as Anticancer Agents
65926
  1. Pharmaceuticals
  2. Biotechnology
Cushman, Mark S
Structure-Activity Relationships of Azaindenoisoquinolines
66042
  1. Biotechnology
  2. Pharmaceuticals
Cushman, Mark S
Dual Tyrosyl-DNA Phosphodiesterase/Topoisomerase Inibitors
66149
  1. Chemical Engineering
  2. Pharmaceuticals
Cushman, Mark S
Synthesis and Evaluation of Topoisomerase 1 Inhibitors
63012
  1. Chemical Engineering
  2. Pharmaceuticals
Cushman, Mark S
Antimicrobial Activity of Substituted Thiazoles Against MRSA
2013-CUSH-66348
  1. Medical/Health
Cushman, Mark S

Details

Dr. Mark S. Cushman is a Distinguished Professor of Medicinal Chemistry at Purdue University. He received his Pharm. D. and Ph.D. from the University of California Medical Center and performed his Postdoctoral work at the Massachusetts Institute of Technology. Dr. Cushman's work has been recognized with numerous awards. Most recently (2012), he was awarded the distinction of Fellow of the American Association for the Advancement of Science, the Chaney Scholar Award for Exceptional Research, Purdue, and was appointed Associate Editor of the Journal of Medicinal Chemistry. Dr. Cushman's research focuses on the design and synthesis of a variety of molecules that interact with specific enzymes and membrane-bound receptors including the design, synthesis, and testing of potential anti-AIDS agents, anticancer agents, and antibiotics.

For additional information, visit Dr. Cushman's Purdue website: http://www.mcmp.purdue.edu/faculty/?uid=cushman